Exencial Wealth Advisors, LLC Atara Biotherapeutics, Inc. Transaction History

Exencial Wealth Advisors, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 13, 2019	SELL	$12.03 - $19.94 $126,315 - $209,370	-10,500 Closed	0 $0
Q1 2019 May 08, 2019	BUY	$28.4 - $41.74 $127,800 - $187,830	4,500 Added 75.0%	10,500 $417,000
Q4 2018 Feb 06, 2019	BUY	$30.9 - $42.97 $185,400 - $257,820	6,000 New	6,000 $208,000

2.89M

Ticker ATRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,362,304
Market Cap $804M
Description
Atara Biotherapeutics, Inc., an off-the-shelf T-cell immunotherapy company, develops treatments for patients with cancer, autoimmune, and viral diseases in the United States. It is developing tabelecleucel, a T-cell immunotherapy that is Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) driven post-transplant lymphoproliferat...

Get notified when there are updates to the investment portfolio of Exencial Wealth Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Exencial Wealth Advisors, LLC with notifications on news.